Months and Severity Score (MOSES) in a Phase III trial (PARCER): A new comprehensive method for reporting adverse events in oncology clinical trials.
Ranjan N, Chopra S, Mangaj A, Rane P, Charnalia M, Kannan S, Dora T, Engineer R, Mahantshetty U, Gurram L, Mittal P, Ghosh J, Maheshwari A, Shylasree TS, Gupta S, Shrivastava SK.
Ranjan N, et al.
EClinicalMedicine. 2022 Apr 16;47:101390. doi: 10.1016/j.eclinm.2022.101390. eCollection 2022 May.
EClinicalMedicine. 2022.
PMID: 35480072
Free PMC article.